|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
CEL-SCI (CVM) Reports First Quarter 2013 Financial Results
2/11/2013 6:20:47 AM
CEL-SCI Corporation (NYSE MKT: CVM) reports financial results for the fiscal quarter ended December 31, 2012.
CEL-SCI reported that net loss available to shareholders for the quarter ended December 31, 2012 was ($2,310,246) versus ($4,156,833) during the same quarter ended December 31, 2011. Net loss per common share, (basic) was ($0.01) for the quarter ended December 31, 2012 versus ($0.02) during the same quarter ended December 31, 2011. The operating loss for the quarter ended December 31, 2012 was ($5,044,457) versus an operating loss of ($4,443,276) during the same quarter ended December 31, 2011.
|
|
|
|
|
|
|
|
|
|
|